PriceTargets.com logo

Bioceres Crop Solutions - BIOX Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $12.13
  • Forecasted Upside: 78.31%
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 4 Buy Ratings
  • 2 Strong Buy Ratings
$6.80 As of 12/17/2024 01:00 AM ET
▲ +0.03 (0.44%)

This chart shows the closing price for BIOX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Bioceres Crop Solutions Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BIOX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BIOX

Analyst Price Target is $12.13
▲ +78.31% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Bioceres Crop Solutions in the last 3 months. The average price target is $12.13, with a high forecast of $13.00 and a low forecast of $9.50. The average price target represents a 78.31% upside from the last price of $6.80.

This chart shows the closing price for BIOX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 6 contributing investment analysts is to buy stock in Bioceres Crop Solutions. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/26/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/24/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/23/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/22/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/20/2024
  • 2 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/18/2024
  • 2 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/17/2024
  • 2 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/17/2024

Latest Recommendations

  • 2 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/13/2024Canaccord Genuity GroupLower TargetBuy ➝ Buy$10.00 ➝ $9.50
10/21/2024OppenheimerLower TargetOutperform ➝ Outperform$16.00 ➝ $13.00
10/17/2024Canaccord Genuity GroupLower TargetBuy ➝ Buy$12.50 ➝ $10.00
9/11/2024Canaccord Genuity GroupLower TargetBuy ➝ Buy$17.00 ➝ $12.50
9/11/2024Roth MkmLower TargetBuy ➝ Buy$15.00 ➝ $13.00
9/11/2024OppenheimerLower TargetOutperform ➝ Outperform$17.00 ➝ $16.00
9/11/2024Lake Street CapitalLower TargetBuy ➝ Buy$25.00 ➝ $13.00
7/19/2024Canaccord Genuity GroupUpgradeStrong-Buy
7/19/2024Canaccord Genuity GroupReiterated RatingBuy$17.00
7/2/2024Roth CapitalUpgradeStrong-Buy
7/2/2024Roth MkmInitiated CoverageBuy$15.00
2/9/2024Roth MkmBoost TargetBuy ➝ Buy$20.00 ➝ $21.00
11/1/2023Roth MkmLower TargetBuy ➝ Buy$31.00 ➝ $20.00
9/12/2023Roth MkmReiterated RatingBuy ➝ Buy$31.00
9/12/2023Lake Street CapitalLower TargetBuy ➝ Buy$30.00 ➝ $25.00
8/16/2023Roth MkmReiterated RatingBuy ➝ Buy$31.00
4/5/2023OppenheimerInitiated CoverageOutperform$15.00
11/11/2022Lake Street CapitalBoost Target$25.00 ➝ $30.00
9/30/2022Canaccord Genuity GroupInitiated CoverageBuy
10/8/2021Roth CapitalInitiated CoverageBuy$21.00
9/10/2021Lake Street CapitalReiterated RatingBuy$25.00
5/7/2021Brookline Capital ManagementReiterated RatingBuy
4/8/2021Lake Street CapitalBoost TargetBuy$15.00 ➝ $20.00
3/15/2021Lake Street CapitalInitiated CoverageBuy$15.00
2/4/2020Brookline Capital ManagementReiterated RatingBuy
(Data available from 12/18/2019 forward)

News Sentiment Rating

1.80 (Strong Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 9 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
5/22/2024
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/21/2024
  • 7 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/21/2024
  • 2 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/20/2024
  • 10 very positive mentions
  • 13 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
Mentions as of
9/19/2024
  • 3 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/19/2024
  • 5 very positive mentions
  • 15 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/18/2024
  • 5 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/18/2024

Current Sentiment

  • 5 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

Bioceres Crop Solutions logo
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Bolivia, Brazil, Colombia, Estonia, the United States, Paraguay, Russia, South Africa, France, Uruguay, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.
Read More

Today's Range

Now: $6.80
Low: $6.61
High: $7.00

50 Day Range

MA: $6.82
Low: $6.08
High: $7.55

52 Week Range

Now: $6.80
Low: $5.71
High: $14.05

Volume

142,126 shs

Average Volume

100,527 shs

Market Capitalization

$427.37 million

P/E Ratio

340.00

Dividend Yield

N/A

Beta

0.51

Frequently Asked Questions

What sell-side analysts currently cover shares of Bioceres Crop Solutions?

The following Wall Street research analysts have issued reports on Bioceres Crop Solutions in the last twelve months: Canaccord Genuity Group Inc., Lake Street Capital, Oppenheimer Holdings Inc., Roth Capital, and Roth Mkm.
View the latest analyst ratings for BIOX.

What is the current price target for Bioceres Crop Solutions?

0 Wall Street analysts have set twelve-month price targets for Bioceres Crop Solutions in the last year. Their average twelve-month price target is $12.13, suggesting a possible upside of 78.3%. Oppenheimer Holdings Inc. has the highest price target set, predicting BIOX will reach $13.00 in the next twelve months. Canaccord Genuity Group Inc. has the lowest price target set, forecasting a price of $9.50 for Bioceres Crop Solutions in the next year.
View the latest price targets for BIOX.

What is the current consensus analyst rating for Bioceres Crop Solutions?

Bioceres Crop Solutions currently has 4 buy ratings and 2 strong buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe BIOX will outperform the market and that investors should add to their positions of Bioceres Crop Solutions.
View the latest ratings for BIOX.

What other companies compete with Bioceres Crop Solutions?

Other companies that are similar to Bioceres Crop Solutions include WisdomTree, Rigetti Computing, Veris Residential, Navient and Ladder Capital. Learn More about companies similar to Bioceres Crop Solutions.

How do I contact Bioceres Crop Solutions' investor relations team?

Bioceres Crop Solutions' physical mailing address is Ocampo 210 bis Predio CCT, Rosario C1, 2000. The company's listed phone number is 543414861100 and its investor relations email address is [email protected]. The official website for Bioceres Crop Solutions is biocerescrops.com. Learn More about contacing Bioceres Crop Solutions investor relations.